ArticleNeoplasia (New York, N.Y.)2013

Sym004, a novel EGFR antibody mixture, can overcome acquired resistance to cetuximab.

Mari Iida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.